Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

DYAI
Dyadic International, Inc.
stock NASDAQ

At Close
Aug 7, 2026 3:59:46 PM EDT
1.01USD+1.000%(+0.01)88,983
0.8600Bid   1.02Ask   0.16Spread
Pre-market
Aug 6, 2026 9:21:30 AM EDT
0.9701USD+0.062%(+0.0006)0
After-hours
Aug 7, 2026 4:00:30 PM EDT
1.00USD-0.990%(-0.01)246
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 20, 2022
08:30AM EST  Dyadic Introduces Novel Method to Produce Synthetic Cannabinoids   GlobeNewswire Inc
Dec 22, 2021
09:13AM EST  Dyadic Announces Up To $690K NIIMBL Coronavirus Grant Under White House's American Rescue Plan   Benzinga
09:13AM EST  Dyadic Announces a NIIMBL Coronavirus GrantUnder the   GlobeNewswire Inc
Dec 21, 2021
09:51AM EST  DYAI: Jumpin' Janssen Jamboree   Benzinga
Dec 20, 2021
02:44PM EST  Dyadic International Shares Down 2.6%; Zacks Small-Cap Research Sets $10 Valuation   Benzinga
Dec 17, 2021
10:18AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021   Benzinga
07:15AM EST  Dyadic Reports Research, License, Collab Deal With J&J's Janssen For Manufacture Of Therapeutic Protein Candidates Using Its C1 Platform   Benzinga
07:00AM EST  Dyadic Announces Research, License and Collaboration Agreement   GlobeNewswire Inc
06:20AM EST  HC Wainwright & Co. Initiates Coverage On Dyadic International with Buy Rating, Announces Price Target of $7   Benzinga
Nov 16, 2021
07:21AM EST  DYAI: Two New Deals & A Pharma in the Wings   Benzinga
Nov 10, 2021
04:54PM EST  Dyadic International Q3 EPS $(0.06) Beats $(0.09) Estimate, Sales $693.00K Beat $600.00K Estimate   Benzinga
04:00PM EST  Dyadic Reports Third Quarter 2021 Financial Results and Highlights   GlobeNewswire Inc
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 9, 2021
08:30AM EST  Dyadic Appoints Chief Business Officer to Executive Leadership Team   GlobeNewswire Inc
Sep 30, 2021
11:22AM EDT  Dyadic International Earnings Perspective: Return On Capital Employed   Benzinga
Sep 29, 2021
12:14PM EDT  From BZ's Small Cap Healthcare Conference: Dyadic International President & CEO, Mark Emalfarb Begins Speaking   Benzinga
Sep 10, 2021
08:30AM EDT  Dyadic to Present at H.C. Wainwright 23rd Annual Global Investment   GlobeNewswire Inc
Aug 12, 2021
04:15PM EDT  Dyadic International Q2 EPS $(0.14) Misses $(0.09) Estimate, Sales $937.09K Beat $550.00K Estimate   Benzinga
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 11, 2021
02:31PM EDT  Mid-Afternoon Market Update: Dow Surges Over 200 Points; HyreCar Shares Plunge   Benzinga
09:03AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Aug. 11, 2021: XLK, ZEV, DYAI, FULC, BLNK   Benzinga
09:00AM EDT  Sorrento and Dyadic Announce Binding Term Sheet to License   GlobeNewswire Inc
08:38AM EDT  UPDATE: Sorrento Will Obtain Exclusive Rights To Utilize Dyadic's C1 Technology; Consideration Includes $10M Upfront Payment And Reimbursement Of Certain DYAI-100 R&D Expenses, With Potential Milestones   Benzinga
08:36AM EDT  Dyadic And Sorrento Announce Binding Term Sheet To License Dyadic's Lead COVID-19 Vaccine Candidate DYAI-100 And C1 Technology For Protein-Based Coronavirus Vaccines And Therapeutics   Benzinga
08:36AM EDT  Dyadic and Sorrento Announce Binding Term Sheet to License   GlobeNewswire Inc
Aug 10, 2021
02:42PM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Jul 29, 2021
10:14AM EDT  Dyadic International Shares See Recent Volume; Zacks Small-Cap Research Sets $10 Price Target   Benzinga
Jul 27, 2021
11:13AM EDT  Dyadic Announces Technology Transfer And Licensing Agreement With South Africa's Rubic Consortium Aiming To 'Develop and Commercialize Vaccines for Distribution Throughout the African Continent'; Financial Details Not Disclosed   Benzinga
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jun 28, 2021
08:30AM EDT  Dyadics C1 Production Platform Utilized in ZAPI   GlobeNewswire Inc
Jun 22, 2021
08:12AM EDT  The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal   Benzinga
Jun 18, 2021
07:46AM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Jun 3, 2021
04:42PM EDT  Dyadic International Reports In 8K Filing Unit Entered Into Amendment To Its Master Services Agreement With CR2O; Says Amended MSA Restated Unit's Engagement With CR2O To Oversee, Perform Certain Pre-Clinical And Clinical Trial Services   Benzinga
May 30, 2021
08:41AM EDT  DYAI: 1Q:21 Results   Benzinga
May 26, 2021
09:26AM EDT  Dyadic's Stock Jumps On COVID-19 Vaccine Development Pact In India   Benzinga
08:31AM EDT  Dyadic Announces Development Of COVID-19 Vaccine In India   Benzinga
May 18, 2021
07:44AM EDT  The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO   Benzinga
May 13, 2021
04:05PM EDT  Dyadic International Q1 EPS $(0.12) Misses $0.09 Estimate, Sales $461.00K Up From $315.37K YoY   Benzinga
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
May 3, 2021
08:30AM EDT  Dyadic to Present at Upcoming Events   GlobeNewswire Inc
Apr 30, 2021
07:31AM EDT  The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs   Benzinga
Apr 22, 2021
08:30AM EDT  Dyadic International Hosting a Fireside Chat   GlobeNewswire Inc
Apr 13, 2021
06:01AM EDT  DYAI: Headed to the Clinic   Benzinga
Mar 30, 2021
04:01PM EDT  Dyadic International Reports FY20 EPS $(0.34) Down From $(0.31) YoY, Sales $1.60M Down From $1.68M YoY   Benzinga
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
04:04AM EDT  Earnings Scheduled For March 30, 2021   Benzinga
Mar 29, 2021
08:31AM EDT  Dyadic Says Advancing COVID-19 Vaccine Candidate DYAI-100 Phase I Trial   Benzinga
08:30AM EDT  UPDATE -- Dyadic Advancing Proprietary Owned COVID-19 vaccine   GlobeNewswire Inc
07:00AM EDT  EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies announces the Schedule of the 4th Emerging Growth Conference.   GlobeNewswire Inc
Mar 27, 2021
01:01PM EDT  The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week   Benzinga
Mar 23, 2021
09:03AM EDT  Dyadic And Medytox To Develop Vaccines Against COVID-19 Variants   Benzinga
Mar 22, 2021
10:58PM EDT  Dyadic International Inc. (DYAI) and South Korea's Medytox Inc. will co-develop C1 manufactured COVID-19 vaccines and/or boosters, which will, if successful, be used to immunize people against two or more of the current and future COVID-19 variants, Dyadic said in a statement.   RTTNews
02:34PM EDT  Mid-Afternoon Market Update: Nasdaq Jumps Over 200 Points; Dyadic International Shares Spike Higher   Benzinga
12:11PM EDT  Mid-Day Market Update: Support.com Jumps Following Merger News; Odonate Therapeutics Shares Slide   Benzinga
08:33AM EDT  Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants   Benzinga
Mar 18, 2021
09:12AM EDT  Dyadic's COVID-19 Vaccine Candidate Comes One Step Closer To Enter Human Trials   Benzinga
08:43AM EDT  Dyadic Says Advancing Towards Human Clinical Trial Of Its SARS-CoV-2-S-RBD Vaccine Candidate DYAI-100   Benzinga
08:30AM EDT  Dyadic Advancing Towards Human Clinical Trial of   GlobeNewswire Inc
Mar 9, 2021
09:17AM EST  Dyadic Says Announces Scientific Achievements Reported During ZAPI Stakeholders Virtual Meeting   Benzinga
08:30AM EST  Dyadic Announces Scientific Achievements Reported During ZAPI   GlobeNewswire Inc
Feb 2, 2021
09:03AM EST  Dyadic Enters Collaboration With TurtleTree Scientific To Develop Recombinant Protein Growth Factors   Benzinga
Jan 4, 2021
09:03AM EST  Dyadic Biotechnology Is On A Quest To Find A Solution For COVID-19   Benzinga
Dec 9, 2020
11:33AM EST  Biotech CEOs Talk Vision, Cash Burn, Catalysts At Benzinga Global Small Cap Conference   Benzinga
Nov 12, 2020
04:36PM EST  Dyadic International Q3 EPS $(0.09) Misses $(0.08) Estimate, Sales $416.36K Beat $300.00K Estimate   Benzinga
07:44AM EST  The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal   Benzinga
04:18AM EST  Earnings Scheduled For November 12, 2020   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Oct 12, 2020
08:37AM EDT  Dyadic Highlights Updates On COVID-19 Initiatives   Benzinga
Oct 1, 2020
08:04PM EDT  DYAI: Dyadic and VTT Developing Production Method for SARS-CoV-2 Vaccines   Benzinga
Sep 17, 2020
08:39AM EDT  Dyadic Announces Collaboration With Jiangsu Hengrui Medicine For Biologic Drug Development   Benzinga
Aug 13, 2020
04:37PM EDT  Dyadic International Q2 EPS $(0.10) Misses $(0.04) Estimate, Sales $524.27K Up From $391.00K YoY   Benzinga
08:18AM EDT  The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller   Benzinga
04:03AM EDT  Earnings Scheduled For August 13, 2020   Benzinga
Jul 15, 2020
08:31AM EDT  Dyadic International Announces Fully Funded Human Health R&D Collaboration With A Pharmaceutical Company   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC